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Immunologic unresponsiveness (paralysis) to pneumococcal polysaccharide, 
first described in detail by Felton  (1-5),  represents a  simple,  easily manipu- 
lated model for the study of the unresponsive state. It is now generally agreed 
that paralysis to polysaccharides and unresponsiveness to protein antigens are 
both expressions of the same basic biologic mechanisms (6).  Current evidence 
supports the concept that the different examples of unresponsiveness all repre- 
sent a  specific, central depression of antibody synthesis and not a  binding of 
antibody  by  excess  antigen  (7-18).  In  contrast  to  protein  antigens,  pneu- 
mococcal polysaccharide appears not to be readily metabolized by mice and 
therefore to have a very long half-life in these animals. Possibly as a consequence 
of the prolonged persistence of antigen, paralysis to polysaccharides is readily 
induced in  adult  animals  by a  single injection of relatively small  amounts. 
This is in contrast with the extended course of injections generally required to 
obtain unresponsiveness to protein antigens. 
A number of experiments were undertaken in order to examine in detail the 
induction phase of paralysis to pneumococcal polysaccharide. Specifically, an 
attempt was made to answer the following questions: (a) What is the quantita- 
tive effect of immunization upon subsequent induction of unresponsiveness? 
(b) Can a  transient phase of immunization be demonstrated prior to induction 
of unresponsiveness? (c) Does "low dose" paralysis, such as recently described 
by Mitchison (19)  for bovine serum albumin, exist for pneumococcal polysac- 
charide? (d) Is intense nonspecific stimulation of lymphoretlcular tissues per se 
capable of altering induction of unresponsiveness or of terminating an estab- 
fished state of unresponsiveness as has been suggested by previous work (20- 
24)? 
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Results of experiments designed to answer these questions are presented in 
this  communication. 
Materials and Methods 
Mice.--Adult, male, Swiss Webster mice  weighing 20 to 25 g were used throughout. 
Polysaccharide.--Type II  pneumococcal polysaecharide  (Squibb  lot  27276)  (SII)  was 
kindly provided by Dr.  C. M. MacLeod (Department  of Medicine, New York University 
Medical Center). This preparation was used in all experiments with one exception which is 
indicated  in the text.  In this  instance Type II polysaccharide prepared  by Dr.  Paul.  D. 
Hoeprich (Department of Medicine, University of Utah College of Medicine) was used. 
Bacteria.--Diplococcus pneumoniae Type II (strain D39S) and Type III (strain A66) were 
used to chaUenge  mice. The pneumocoeci  were kindly provided and cultured by Miss Marjorie 
Krauss  (Department  of Medicine, New York  University Medical  Center).  Cultures were 
incubated for 18 hr at 37°C, in neopeptone beef heart infusion broth containing approximately 
0.5% defibrinated rabbit blood. 
A  formalinized, heat-killed  suspension of  Corynebacterlum parvum (strain  936B) was 
generously given by Dr. G. Biozzi (L'H6pital Broussais, Paris). 
Treatment of M/ce.--Appropriate doses of SII were injected, intraperitoneally, in 0.5 ml of 
phosphate-buffered saline (PBS) (0.15 ~ NaC1, 0.01 ~ potassium phosphate buffer, pH 7.5) as 
indicated in the text. 
C. parvum was administered intravenously in a dose of 0.5 mg (dry weight) contained in a 
volume of 0.25 ml of PBS. 
Mice were challenged by a single intraperitoneal  injection of 0.5 ml of an appropriately 
diluted overnight culture of fully virulent, recently mouse passaged pneumoeci. Mice were 
observed for deaths occurring over a period of 5 days. Culture dilutions were prepared  in 
nutrient  broth. The dilution used for challenge of experimental mice was 10  -7. In every experi- 
ment, groups of normal mice, serving as virulence controls, received 10  -7  ,  10  -8  , and 10  -9 
dilutions of the overnight culture. Based upon deaths among the virulence controls, pneu- 
mococcal challenges (10-  7 dilution) were found to generally contain between 10 and 100 lethal 
doses. Any experiment was discarded ff the challenge did not fall within these limits of viru- 
lence. Virulence controls receiving the 10  -7 dilution died, without exception, in all experiments. 
These have been omitted from the tables for the sake of brevity. It should be emphasized that 
all experiments were designed so that groups of animals to be compared were challenged simul- 
taneously with the same bacterial suspension. Details of individual  experiments are indicated 
in the footnotes to the appropriate tables. 
EXPERIMENTAL RESULTS 
Induction of Paralysis in Immunized M~e.--The effect of immunization  with 
SII upon the subsequent response of mice to varying dosages of SII is indicated 
in Table I. From the response of normal mice, also included in this table, it is 
clear that maximal protection (h~mu~izadon) follows the intraperitoneal injec- 
tion of 0.05 #g of the SII preparation I  wk before challenge. With this polysac- 
charide preparation and with the Swiss Webster mice used approx~ately 50 % 
protection was consistently the maximum attainable. As the dose of po]ysac- 
charide was increased above 0.05  #g the  degree  of protection decreased pro- 
gressively until, with  I00 #g of antigen, little or no protection was detected. 
From previous work (I-5, 25) it is known that animals receiving these higher GREGORY  W.  SlSKIND  AND  JAMES  G.  HOWARD  419 
doses of polysaccharide are subsequently incapable of responding to an optimal 
immunogenic dose. In all experiments, therefore, such a decrease in protection 
at relatively high dose levels has been taken to signify immunological paralysis 
(unresponsiveness or tolerance). Progressively poorer protection was also ob- 
observed with doses of SII below 0.05 #g, but such animals are, of course, capa- 
ble of responding further to optimal immunogenic doses of polysaccharide (see 
Table V). 
If the response of preimmunized animals is compared with that of normal 
animals, it is apparent that the maximum degree of immunization attained is 
identical in both groups. This lack of any obvious "booster" response  is con- 
TABLE  I 
Effect of Previous Immunization upon the Response of Mice to SII* 
Dose SII 
100 
25 
10 
2 
0.5 
0.05 
0.OO5  8/20 
0.0005  4/20 
0.00005  4/44 
0  O/30 
Result of challenge 
No. survived/No, challenged (per cent survival) 
Normal 
i/30  (3) 
11/60 (18) 
14/58 (24) 
35/91  (39) 
24/6o  (40) 
9/19  (47) 
t40) 
(20) 
(9) 
(0) 
Prelmmunized 
1/29  (3) 
7/60  (12) 
7/60 (i2) 
24/98  (25) 
17/60 (28) 
9/20  (45) 
8/20  (40) 
8/20  (40) 
22/45  (49) 
50/104 (48) 
* Prdmmunized with 0.5  /~g SH intraperitoneally. 7  days later given varying doses of 
SII and challenged with virulent Type H  pneumococci after a further 7 days. 
sistent with classical observations using purified polysaccharide antigens (26) 
On the other hand, in contrast to previous observations (4,  27, 28)  (see Dis- 
cussion), no elevation of the paralysis threshold was observed. In fact, with 0.5, 
2, and 10 #g SII, preimmunizafion appeared to facilitate subsequent induction 
of unresponsiveness. It should be noted that, in order to assure confidence in the 
differences observed, large groups of mice (60 to 100) were used over the more 
critical part of the dose range. 
Desensitization  of Immunized  Mice.--It  was  of  interest  to  determine  the 
mount of polysaccharide required to bind all of the available antibody present 
in an immunized mouse and to compare this with the amount required to induce 
paralysis. From Table II it is clear that immunized mice can be rendered nearly 
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0.5 #g of SII,  1 day previously. In fact, even 0.05 #g was partially effective. 
Thus, normally highly immunogenic doses of polysaccharide are sufficient to 
bind most available antibody in maximally immunized mice. That is, induction 
of paralysis requires far more antigen than is required for simple desensitiza- 
tion. Furthermore, by comparison with Table I, it is clear that this desensitiza- 
tion is, as expected, quite transient when compared with the long-lasting state 
of paralysis. That even 100 #g of SII failed to completely desensitize may be the 
result  of continuing  antibody synthesis  following rapid  phagocytosis of the 
injected  polysaccharide. 
TABLE II 
Desensitization of Immunized Mice with SII* 
Dose of SII 
/*g 
100 
25 
10 
2 
0.5 
0.05 
0.005 
0.0005 
0.00005 
0 
Normal mice 
Result of challenge 
No. survived/No,  challenged  (per  cent survival) 
4/34  (12) 
3/33  (9) 
2/35  (6) 
4/35  (11) 
4/35  (11) 
12/34  (35) 
19/34  (56) 
17/34  (50) 
14/25  (56) 
20/40 (50) 
0/2o  (0) 
* Mice were immunized with 0.5 ~g SII.  14 days later they received varying doses of 
SII and were challenged 1 day later with virulent Type II pneumococci. 
Demonstration of Immunization Prior to the Appearance of Unresponsiveness.-- 
While it is clear from the results of previous workers (7-18) that fully paralyzed 
mice are not producing antibody, it appeared possible that an early and transi- 
ent  phase  of antibody  synthesis might  occur prior  to  the  establishment  of 
complete unresponsiveness. We have, therefore, examined in detail the immune 
status of mice, at daily intervals, immediately following doses of polysaccharide 
ranging from 0.005 to 100/zg. In order that all the mice in any one experiment 
should be challenged with the same bacterial suspension groups of 5 to 20 mice 
were injected with the varying doses of antigen 1, 2, 3, 4, 5, 7, and 9 days prior to 
challenge. Initial experiments indicated that any early phase of weak immunity 
could be detected 4 to 7 days after injection of 10 and 25/zg of antigen. These 
observations were  subsequently made  consistently on  replicate experiments. GREGORY  W.  SISKIND  AND  JAMES  G.  HOWARD  421 
The cumulative data are presented in Table HI. It is apparent from this table 
that with paralyzing doses of SII (10 and 25 #g) an early phase of immunization 
can be detected. It is further clear that with the lowest doses of SII studied 
(0.05 and 0.005 #g), the onset of protection was 1 day earlier than with 0.5 or 
2#g. 
In view of the small magnitude of the effects observed, large groups of ani- 
mals were employed at critical dose levels and, in addition, the entire experi- 
ment was repeated using a second preparation of SII polysaccharide (Table IV). 
Although minor quantitative differences between these two experiments are 
apparent,  the essential qualitative findings presented in Table III were sub- 
stantiated. 
TABLE HI 
Induct4on of Immunization and Unresponsiveness to SII 
Results of challenge [No. survived/No, challenged (per cent survival)] 
Dose  of  SII  Days before challenge* 
1  3  4  5  7 
t~g 
10 
2 
0.5 
0.05 
0.005 
0/15  (0) 
1/45  (2) 
1/15  (7) 
1/15  (7) 
0/15  (0) 
0/15  (0) 
0/15  (0) 
2 
0115 (0) 
s/4s  (7) 
0115 (0) 
0115 (0) 
~/15 (0) 
1115 (7) 
0115 (0) 
2/35 (6) 
4/74  (5) 
3/45 (7) 
2/35 (6) 
2/35 (6) 
7/35  (20) 
12/35  (34) 
0/25 (0) 
9/64  (14) 
5/35 (14) 
8/25 (32) 
10/25 (4O) 
12/25  (48) 
7/23 (30) 
1/35  (3) 
11/74 (15) 
9/45 (20) 
12/35 (34) 
14/34 (41) 
20/35  (57) 
10/34 (28) 
3/34 
12/74 
9/44 
12/35 
15/35 
17/35 
17/35 
9 
(9)  O/lO (0) 
(16)  2/44 (5) 
(21)  3/4o  (8) 
(34)  2/10 (20 
(43)  4/10  (40 
(48)  5/lO (5o 
(48)  5/10 (50 
* Mice received doses of $II at indicated number of days before challenge with virulent 
Type II pneumococci. Of 40 normal mice challenged along with experimental mice, none 
survived challenge. 
It was necessary to exclude the unlikely possibility of increased nonspecific 
resistance being responsible for the apparent transient immunity following high 
doses of polysaccharide. For this purpose three groups of 20 normal mice were 
injected with 25 #g SII, 3, 5, and 7 days prior to challenge with approximately 
20 lethal doses of Type III pneumococci. All 60 animals died. Thus, nonspecific 
protection appears not to be responsible for the early immunity in Tables III 
and IV. Furthermore, it seems likely that the degree of early protection ob- 
served is a highly dampened reflection of the immune response as the excess of 
antigen available would certainly be expected to combine with a major part of 
any antibody formed (see Table II and reference 15). 
Unsuccessful Attempt  to Obtain  "Low Dose" Paralysis.--It has been shown 
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unresponsiveness to protein antigens by repeated injections of subimmunogenic 
doses.  Similar results  have  been  obtained by several  workers  (29-31)  using 
different antigens. As indicated in Table V, repeated injections of 5 X  10  -6 #g 
SII failed either to immunize or to impair the response of mice to an immuno- 
genic dose of polysaccharide. A 10-fold higher dose (5 X  10  -s #g), shown to be 
TABLE  IV 
Induction of Immunization and  Unresponsiveness to SII 
Results of challenge [No. survived/No, challenged (per cent survival)] 
Dose oi SII  Days before challenge* 
1  3  4  5  7 
~g 
25 
I0 
5 
2 
0.5 
0.05 
O.0O5 
O/lO 
0/lO 
0/10 
O/lO 
O/lO 
o/1o 
O/lO 
2 
(0)  0/10  (0) 
(o)  1/lO  (to) 
(0)  0/10  (0) 
(o)  O/lO (o) 
(0)  1/10  (10) 
(o)  O/lO (o) 
(o)  O/lO (o) 
1/20 (5) 
3/19  (16) 
1/20  (5) 
3/20  (15) 
2/20  (10) 
3/20  (15) 
7/20  (35) 
4/20  (20) 
2/20  (10) 
2/20  (10) 
2/20  (10) 
9/20  (45) 
12/20  (60) 
2/20  (10) 
0/20  (o) 
4/20  (20) 
5/20  (25) 
5/20  (25) 
10/20 (50) 
8/20  (40) 
0/20  (0) 
1/20 (5) 
0/20  (o) 
2/20  (10) 
3/20  (15) 
8/20  (40) 
6/20  (30) 
* Mice received the dose of polysaccharide indicated at varying numbers of days prior 
to challenge with virulent Type II pneumococci. The Hoeprich preparation of SII was used 
for this experiment only. Of 15 normal mice challenged along with experimental mice, none 
survived challenge. 
TABLE  V 
Eject of Repeated Injections of Small Doses of SII on Immunologic  Status* 
Dose of SII 
~g 
0 
5  X  10  ~ 
5 X  10  -s 
0 
5 X  10  -5 
5  X  10  -s 
Duration of injection 
wk 
3 
6 
3 
6 
Result of challenge 
No. survived/No, challenged  (per cent survival) 
No further treatment 
0/5  (0) 
1/19 (5) 
0/17  (0) 
O/lO (o) 
5/19  (26) 
2/17  (12) 
Immunizing dose of SII 
16/20  (80) 
15/19  (79) 
17/i8  (95) 
12/20  (60) 
12/19  (63) 
10/17  (59) 
* Mice received injections of SII twice weekly for the indicated number of weeks. 4 days 
after the last injection half of each group received an immunizing injection of SII and 1 wk 
later all mice were challenged with virulent Type II pneumococci. In the first set of experi- 
ments indicated in the table, the immunizing dose used was 0.5/~g SII while with the second 
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feebly immunogenic in Table I, induced weak immunity upon repeated injection 
but failed to cause any change in response to subsequent immunization. Thus, 
no evidence for a "low dose" zone of paralysis, analogous to that described by 
Mitchison (19), was elicited with this polysaccharide antigen. 
Effect  of  Lymphoreticular  Stimulation  upon  Response  to  SII.--Previous 
workers  have  demonstrated  termination  of  immunologic  unresponsiveness 
and/or increased resistance to its induction by treatment with agents known to 
cause  lymphoreticular  stimulation  (20--24).  Corynebacterium  parvum  has 
recently been shown to cause massive proliferation of RE ceils (32), to have a 
TABLE VI 
Effect of C. Parvum on Immunologic Response of Mice to SII 
Result of challenge 
No. survived/No, challenged (per cent survival) 
Dose of SII 
C. parvum simultaneously  Normal mice  C. par~um before SIP  with SII~ 
~g 
lOO 
25 
lO 
2 
0.5 
0.05 
o.oo5 
o.ooo5 
o.oooo5 
o 
1/15 (7) 
2/15  (13) 
6/26  (23) 
8/24  (33) 
10/25  (40) 
18/25  (62) 
12/25 (48) 
2/15  (13) 
1/15 (7) 
0/20  (o) 
o/15  (0) 
2/15  (13) 
8/24  (33) 
17/25 (68) 
16/23  (70) 
20/24  (83) 
17/24  (71) 
4/16  (24) 
2/i5  (13) 
0/9  (0) 
0/10 m) 
3/10 (30) 
3/9  (33) 
4/10 (40) 
7/10 (60) 
2/10 (20) 
1/10  (10) 
* Mice given varying doses of 8II intraperitoneally 1 wk after  C. parvum intravenously. 
Mice were challenged with virulent Type II pneumococci 1 wk after SII. 
Mice received  C. par~um intravenously and SII intraperitoneally i  to 2 hr later. Mice 
were challenged with virulent Type II pneumococci 1 wk later. 
potent adjuvant effect on immunization (33) and to lead to a marked increase in 
the number of splenic cells synthesizing antibody to a concomitantly adminis- 
tered antigen (34). The effect of pretreatment with this agent on the response of 
mice to SII polysaccharide was studied and the results are presented in Table 
VI. The greater amplitude of the dose response curve following pretreatment 
with C. parvum is consistent with the previously described adjuvant effect of 
this material (33). Despite this increase in antibody formation seen even on the 
paralysis side of the dose response curve, there does not appear to be any signifi- 
cant shift in the tolerance induction threshold. When given simultaneously with 
SII, C. parvum was without any detectable effect. 
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unresponsiveness to SII polysaccharide. Table VII indicates that C. parvum, 
administered 1 wk after polysaccharide, and 2 wk before challenge, was totally 
ineffective in terminating paralysis. 
TABLE  VII 
Failure  of C. par~um to Terminate  Paralysis* 
Dose of SH 
/*g 
lOO 
25 
10 
0.5 
0.05 
0.005 
0.0005 
0.OOO05 
0 
Result of challenge 
No. survived/No,  challenged (per cent survival) 
C. parvum treated  Normal mice 
1/10 00) 
2/15  (13) 
7/25 (28) 
6/15  (4o) 
7/15  (47) 
4/15  (27) 
0/15  (0) 
i/i5 (7) 
0/15  (0) 
1/10  (10) 
2/15  (13) 
6/25  (24) 
6/15  (4o) 
8/14  (57) 
4/14  (29) 
3/15  (20) 
0/15  (0) 
0/10  (0) 
* Groups of mice received  doses of SII  as indicated.  1  wk later  half of each group  re- 
ceived C. parvum intravenously. All mice were challenged with virulent Type II pneumococic 
3 wk after receiving SII. 
DISCUSSION 
It is clear from the data presented that paralysis to a polysaccharide antigen 
can be readily induced in previously immunized mice. In fact, preimmunizadon 
may facilitate slightly the induction of unresponsiveness. Thus, in the system 
studied, immune cells are no more difficult to render tolerant than are normal 
cells.  Several previous workers have demonstrated  that  tolerance to various 
antigens could be induced in previously immunized animals (4, 27-29, 35-42). 
Generally, these studies did not permit detailed quantitative assessment of the 
relative tolerance induction thresholds of normal and immune animals. Dresser 
(27),  however, using bovine gamma  globulin,  has  reported that  comparable 
doses of antigen produced a lower degree or lack of tolerance in immunized as 
compared  with  normal  recipients.  Makela  and  Mitchison  (28),  using  a  cell 
transfer system and a protein antigen, presented evidence that relatively high 
concentrations of antigen are required to paralyze cells from previously immu- 
nized donors.  The data referred to on the response curves for normal cells, 
however,  came  from  studies  using  intact  animals  and  are,  therefore,  not 
strictly  comparable.  Felton  et  al.  (4)  reached  a  similar  conclusion  for  a 
polysaccharide antigen  from a  rather  limited  series of observations.  On  the 
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response curves utilizing large numbers of animals, have failed to support this 
contention. Considering the available evidence it appears reasonable that the 
modulation of tolerance induction in preimmunized animals is very likely the 
result of alterations in the cellular distribution and subsequent catabolism of 
antigen as a result of the presence of antibody. The rate of elimination from the 
animal of a  polysaccharide antigen, which is rapidly phagocytozed but not 
metabolized, may be less affected by the presence of antibody than is the rate of 
elimination from the host of proteins which once phagocytozed are  readily 
metabolized. 
It has been shown here that a  transient period of weak immunity can be 
detected prior to establishment of complete unresponsiveness. Several previous 
workers  (19,  43-45),  using protein  or  cellular  antigens,  have  observed  the 
development of immunity prior to, or simultaneously with, the development of 
unresponsiveness. In contrast, Michie and Howard (46)  failed to detect any 
immune phase  prior  to  the  onset of  tolerance  induced  with  high  doses  of 
histocompatibility antigens, despite the fact that the neonatal animals used were 
shown to be capable of giving an immune response to lower doses of antigen. 
The failure of Sercarz and Coons (8, 13) to demonstrate any antibody-forming 
cells  in fully paralyzed mice suggests that the initial antibody-forming cells 
soon cease to produce detectable antibody. Whether this early antibody forma- 
tion is important in the induction of unresponsiveness, as has been suggested by 
Rowley  and  Fitch  (43-45),  and  possibly  indicated  by  the  greater  ease  of 
paralyzing immune mice reported here, cannot be said at present. 
Our failure to induce tolerance with repeated subimmunogenic doses of poly- 
saccharide would appear to represent a distinction from the outcome following 
similar treatment with certain protein antigens. A "low dose" zone of paralysis, 
of the type first described in detail by Mitchison (19) has also been observed by 
several other workers (27, 29-31)  using a variety of different proteins. Although 
it was originally suggested by Mitchison that detection of "low dose" paralysis 
might be restricted to antigens of low immunogenicity, the reported ability of 
Nossal and Ada (29) to elicit this phenomenon with flagellin, a highly immuno- 
genic protein, suggests that this limitation need not apply rigorously. The in- 
ability  of  a  polysaccharide  antigen  to  produce  a  comparable  "low  zone" 
paralysis cannot be satisfactorily explained, but may be related to differences in 
the doses of antigen used with polysaccharide as compared with proteins. For 
example, the maximally immunogenic dose of polysaccharide is,  on a  weight 
basis,  approximately 106-fold below  the  optimal immunizing dose of bovine 
serum albumin as reported by Mitchison. In fact, on a weight basis, amounts of 
antigen which induce "low dose" paralysis with protein antigens would tend to 
produce "high dose" paralysis with polysaccharide antigens. It is well known 
that large polysaccharide molecules are readily phagocytozed (47).  With the 
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should be highly efficient and thus the amount of antigen remaining free to 
interact with cells susceptible to tolerance induction would be exquisitely small. 
It has been reported that an established state of immunological unresponsive- 
ness can be terminated by injection of complete Freund's adjuvant (21),  endo- 
toxin (20),  or low dose X-irradiation (23,  24). In some cases these procedures 
can also render normal animals more resistant to induction of unresponsiveness 
(21, 22). These agents have in common a sfimulatory action upon the lympho- 
reticular system. It appeared likely that the ability to alter immunologic un- 
responsiveness in this manner might be a general property of any agent capable 
of  producing  lymphoreticular  hyperplasia.  C.  parvum which,  as  previously 
discussed, is known to cause massive proliferation of both macrophages and 
lymphoid cells  (32) was shown here to give the expected adjuvant effect upon 
anti-SII antibody formation (33)  but failed completely to alter a  preexisting 
state of unresponsiveness.  Thus,  neither lymphoid hyperplasia nor increased 
phagocytic capacity are, in and of themselves, sufficient to terminate paralysis 
to  a  polysaccharide  antigen.  When  administered  prior  to  SII,  C.  parvum 
resulted in an increase in the amplitude of the immune response throughout the 
dose response curve. Despite this adjuvant effect upon the immune response, 
seen even in the paralytic zone of the dose-response curve, no elevation in the 
threshold dose for tolerance induction was seen.  One possible explanation for 
this finding is that the induction of polysaccharide paralysis is related to the 
concentration of antigen present,  rather  than  to  the  amount of antigen per 
immunologically  competent  cell.  The  fact  that  the  increased  phagocytic 
capacity resulting from C. parvum treatment did not alter induction of un- 
responsiveness suggests either that there is a nonphagocytosable fraction of the 
SII preparation which is crucial for tolerance induction, or that phagocytosis of 
antigen does not play any significant role  in  tolerance induction.  We have 
previously shown  (15)  that  throughout the  course  of paralysis some  SII  is 
present which is capable of binding (in vivo) passively administered antibody. 
This polysaccharide disappears with a biologic half-life of 50 days and might 
represent that fraction of antigen which is nonphagocytosable and is responsible 
for induction and maintenance of paralysis. This possibility is consistent with 
the findings of Dresser (31) and of Frei et al. (48) using protein antigens. 
S~RY 
I.  Comparison of dose-response curves indicated that preimmunized animals 
were slightly more susceptible to the induction of immunological paralysis with 
pneumococcal polysaccharide than were normal mice. The results also indicated 
that the paralysis threshold was unaltered by preimmunization. 
2.  Transient  desensitization  of immunized mice  could be  achieved by  an 
amount of polysaccharide far less than that required to induce paralysis. 
3.  A  transient phase of weak immunity was detected prior to the onset of 
paralysis when induced by relatively low paralyzing doses of polysaccharide. GREGORY  W.  SISKIND  AND  JAMES  G.  HOWARD  427 
4.  No "low dose" zone of paralysis (analogous to that obtainable with certain 
protein antigens) could be elicited with pneumococcal polysaccharide. 
5.  Massive proliferation of lymphoreticular tissues induced by Corynebac- 
terium parvum failed to raise the threshold for paralysis induction, but amplified 
the immune response over the entire dose-response curve. Similarly, C. parvu• 
failed to abrogate an established state of paralysis. The results suggest that the 
induction of polysaccharide paralysis is related to the concentration of antigen 
in the animal and is not modified by the number of immunologically competent 
cells. 
The authors would like to thank Mrs. Frances Borden for able technical assistance during 
the course of these experiments. 
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